Detalles de la búsqueda
1.
Pooled analysis of safety data from pediatric Phase II RTS,S/AS malaria candidate vaccine trials.
Hum Vaccin;
7(12): 1309-16, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-22108035
2.
Evaluation of the safety and immunogenicity of the RTS,S/AS01E malaria candidate vaccine when integrated in the expanded program of immunization.
J Infect Dis;
202(7): 1076-87, 2010 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20735271
3.
Safety and immunogenicity of RTS,S/AS01 malaria vaccine in infants and children with WHO stage 1 or 2 HIV disease: a randomised, double-blind, controlled trial.
Lancet Infect Dis;
16(10): 1134-1144, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27394191
4.
Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting.
Vaccine;
33(32): 4025-34, 2015 Jul 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-26072017
5.
Abacavir and the potential risk of myocardial infarction.
Lancet;
371(9622): 1413, 2008 Apr 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-18387668
6.
Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trial.
Lancet Infect Dis;
11(2): 102-9, 2011 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21237715
7.
Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial.
Lancet Infect Dis;
11(10): 741-9, 2011 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-21782519
8.
Risk of myocardial infarction and abacavir therapy: no increased risk across 52 GlaxoSmithKline-sponsored clinical trials in adult subjects.
J Acquir Immune Defic Syndr;
51(1): 20-8, 2009 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19282778
Resultados
1 -
8
de 8
1
Próxima >
>>